T1D Fund
By The Numbers
8.7M
living with T1D globally1
<30%
of people with T1D
meet target A1c2
$90B
annual global economic impact3
1.4M
people living with T1D in the U.S.4
$50B
immunology market by 2022
including T1D 5
Our Team
A dedicated team of investment professionals with vast years of experience in venture capital, drug development, and company building. We strive to understand all facets of T1D. This empowers us to act as subject matter experts who evaluate different opportunities to drive investments towards a cure.
Meet The TeamHow We Invest
We prioritize impact over ownership. Our investments empower us to leverage valuable relationships within Breakthrough T1D’s network of clinicians, regulators, and donors to enable success for our companies.
Learn MoreNews and Press
By using a venture philanthropy model, the T1D Fund is uniquely positioned to create an investment market in T1D.
[The Fund] is different because it's looking for viability and commercial uptake whereas a basic research grant is just about the learning. To advance the mission of Breakthrough T1D, we need both.